LAVA Medtech Acquisition (LVAC) Short Interest Ratio & Short Volume

Short interest is the volume of LAVA Medtech Acquisition shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 6,800 shares of LVAC short. 0.06% of LAVA Medtech Acquisition's shares are currently sold short. Learn More on LAVA Medtech Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.06% of LAVA Medtech Acquisition's floating shares are currently sold short.

LAVA Medtech Acquisition saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 6,800 shares, a decrease of 41.4% from the previous total of 11,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

LAVA Medtech Acquisition currently has issued a total of 14,380,000 shares. Some of LAVA Medtech Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LAVA Medtech Acquisition currently has a public float of 11,380,000 shares.

0.06% of LAVA Medtech Acquisition's shares are currently sold short. Here is how the short interest of companies in the sector of "unclassified" compare to LAVA Medtech Acquisition: Blockchain Coinvestors Acquisition Corp. I (0.16%), Ross Acquisition Corp II (0.01%), Carbon Revolution Public Limited (0.07%), FTAC Emerald Acquisition Corp. (0.75%), Battery Future Acquisition Corp. (0.04%), Captivision Inc. (0.34%), Pyrophyte Acquisition Corp. (0.16%), Alpha Star Acquisition Co. (0.00%), Twelve Seas Investment Company II (0.00%), Enphys Acquisition Corp. (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.05 billion), Occidental Petroleum Co. ($3.06 billion), Moderna, Inc. ($2.37 billion), Paramount Global ($2.14 billion), T. Rowe Price Group, Inc. ($2.13 billion), Coinbase Global, Inc. ($2.00 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.77 billion), CarMax, Inc. ($1.59 billion), and Old Dominion Freight Line, Inc. ($1.56 billion). View all of the most shorted stocks.

Short selling LVAC is an investing strategy that aims to generate trading profit from LAVA Medtech Acquisition as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for LAVA Medtech Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LVAC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LVAC, twice per month. The most recent reporting period available is April, 30 2023.